Shares of Nabriva Therapeutics plc (NASDAQ:NBRV – Get Free Report) crossed above its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of $0.00 and traded as high as $0.0001. Nabriva Therapeutics shares last traded at $0.00, with a volume of 0 shares traded.
Nabriva Therapeutics Stock Performance
The company has a market capitalization of $45.46 million, a price-to-earnings ratio of 0.00 and a beta of 1.53. The company has a current ratio of 0.85, a quick ratio of 0.52 and a debt-to-equity ratio of 0.12.
Nabriva Therapeutics Company Profile
Nabriva Therapeutics plc, a biopharmaceutical company, engages in the development and commercialization of novel anti-infective agents to treat serious infections. The company's product includes SIVEXTRO, an oxazolidinone-class antibacterial for the treatment of acute bacterial skin and skin structure infection (ABSSSI); and XENLETA, a semi-synthetic pleuromutilin antibiotic for oral and IV administration.
Recommended Stories
- Five stocks we like better than Nabriva Therapeutics
- NYSE Stocks Give Investors a Variety of Quality Options
- What’s on the Thanksgiving Table? A Stock Pick for Every Course
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Why Home Depot’s Pain Could Be a Long-Term Investor’s Gain
- What is the Nikkei 225 index?
- Qualcomm’s Bulls Are Running Out of Room to Be Wrong
Receive News & Ratings for Nabriva Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nabriva Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
